Tech Mahindra, Reagene to file patent for molecule that potentially attacks coronavirus SECTIONS Last Updated: May 02, 2021, 06:48 PM IST Share Synopsis Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra. Getty Images IT company Tech Mahindra is in the process of filing a patent, along with Reagene Biosciences, for a drug molecule that can potentially attack coronavirus, according to a senior company official. Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done.